Akaal Pharma is a clinical-stage drug discovery and development company focused on developing novel drugs for the treatment of inflammatory diseases.
leveraging our proven expertise in clinical execution and multiple, high value drug development platforms. Fueled by our entrepreneurial structure and experienced management team, we are advancing multiple late- and early-stage drug development programs in neuroscience, immunology and oncology for numerous ...
leveraging our proven expertise in clinical execution and multiple, high value drug development platforms. Fueled by our entrepreneurial structure and experienced management team, we are advancing multiple late- and early-stage drug development programs in neuroscience, immunology and oncology for numerous ...
leveraging our proven expertise in clinical execution and multiple, high value drug development platforms. Fueled by our entrepreneurial structure and experienced management team, we are advancing multiple late- and early-stage drug development programs in neuroscience, immunology and oncology for numerous ...
Thinking about early-stage disease Two tumour types where drug development is moving to investigate early-stage disease were presented: (1) Non-small cell lung cancer, one of the leading causes of cancer-related mortality. Even after adequate surgical resection, the majority of patients develop ...
Enteris BioPharma, a clinical stage biopharmaceutical CDMO, specializes in oral peptide drug delivery technology, including its Peptelligence® platform.
Importance: Many investigational drugs fail in late-stage clinical development. A better understanding of why investigational drugs fail can inform clinical practice, regulatory decisions, and future research. Objective: To assess factors associated with regulatory approval or reasons for failure of investig...
New drugs in preclinical and early stage clinical development in the treatment of heart failureHeart failurenovel investigational drugsclinical trialsacute heart failurereduced ejection fractionpreserved ejection fractionHeart failure (HF) represents a major health problem because of its high prevalence, high...
In a 5-year follow-up of a case of adult metachromatic leukodystrophy, already diagnosed in the preclinical stage, the development of the symptoms of this disease could be studied in detail: initially, lack of drive, emotional lability a... H Pilz,I Duensing,R Heipertz,... - 《European ...
Applications and examples of the use of these tools — such as Bayesian methodologies — in early- and late-stage drug development are discussed, as well as the advantages, challenges and barriers to their more widespread implementation. This is a preview of subscription content Access options ...